1657014-33-9 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure allows it to be a key component in the development of new medications with potential therapeutic benefits.
Used in Chemical Research:
In the field of chemical research, 2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid serves as a valuable compound for studying the properties and reactions of thiazole-based compounds. Its synthesis and modification can provide insights into the development of new chemical entities with potential applications in various fields.
Used in Material Science:
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid can be utilized in the development of new materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of novel materials with improved characteristics, such as enhanced stability, conductivity, or other desirable properties.
Used in Febuxostat Production:
2-(4-butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid is an impurity of Febuxostat (F229000), which is a xanthine oxidase/xanthine dehydrogenase inhibitor. It plays a role in the production process of Febuxostat, and controlling its presence is crucial for ensuring the purity and efficacy of the final product.
Check Digit Verification of cas no
The CAS Registry Mumber 1657014-33-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,5,7,0,1 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1657014-33:
(9*1)+(8*6)+(7*5)+(6*7)+(5*0)+(4*1)+(3*4)+(2*3)+(1*3)=159
159 % 10 = 9
So 1657014-33-9 is a valid CAS Registry Number.
1657014-33-9Relevant academic research and scientific papers
Synthesis method of Febuxostat isomeride
-
Paragraph 0027; 0065-0067, (2018/08/04)
The invention relates to a synthesis method of Febuxostat isomeride. The method comprises the following steps: firstly ensuring that 2-(3-aldehyde-4- hydroxyphenyl)-4-methylthiazole-5-nonanoic acid-ethyl ester (a compound 1) taken as a raw material and bromobutane are reacted, so as to obtain a compound 2, secondly, performing oximation and dehydration on the compound 2, so as to obtain a cyan compound 3, and thirdly, performing hydrolysis on the compound 3, so as to obtain a compound 4.
